Targeted Therapy and Evolving Research: Where Are We Winning and Losing in Chronic Myeloid Leukemia?
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Mauro: I have been ...
CML is traditionally regarded as a paradigm of precision medicine, under several points of view: 1) it is the first human malignancy whose molecular pathogenesis was unravelled, well before the advent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results